Department of Biochemistry and Molecular Biology, Brody School of Medicine at East Carolina University, Greenville, North Carolina, USA.
Biophys J. 2010 Sep 22;99(6):1861-8. doi: 10.1016/j.bpj.2010.07.018.
Caldesmon is an actin- and myosin-binding protein found in smooth muscle that inhibits actin activation of myosin ATPase activity. The activity of caldesmon is controlled by phosphorylation and by binding to Ca(2+)-calmodulin. We investigated the effects of phosphorylation by p(21)-activated kinase 3 (PAK) and calmodulin on the 22 kDa C-terminal fragment of caldesmon (CaD22). We substituted the major PAK sites, Ser-672 and Ser-702, with either alanine or aspartic acid to mimic nonphosphorylated and constitutively phosphorylated states of caldesmon, respectively. The aspartic acid mutation of CaD22 weakened Ca(2+)-calmodulin binding but had no effect on inhibition of ATPase activity. Phosphorylation of the aspartic acid mutant with PAK resulted in the slow phosphorylation of Thr-627, Ser-631, Ser-635, and Ser-642. Phosphorylation at these sites weakened Ca(2+)-calmodulin binding further and reduced the inhibitory activity of CaD22 in the absence of Ca(2+)-calmodulin. Phosphorylation of these sites of the alanine mutant of CaD22 had no effect on Ca(2+)-calmodulin binding but did reduce inhibition of ATPase activity. Thus, the region between residues 627 and 642 may contribute to the overall regulation of caldesmon's activity.
钙调蛋白是一种存在于平滑肌中的肌动蛋白和肌球蛋白结合蛋白,可抑制肌球蛋白 ATP 酶的活性。钙调蛋白的活性受磷酸化和与 Ca(2+)-钙调蛋白结合的控制。我们研究了 p(21)激活激酶 3(PAK)和钙调蛋白对钙调蛋白 22 kDa C 末端片段(CaD22)的磷酸化作用的影响。我们用丙氨酸或天冬氨酸分别替代主要的 PAK 位点丝氨酸-672 和丝氨酸-702,模拟钙调蛋白的非磷酸化和组成性磷酸化状态。CaD22 的天冬氨酸突变削弱了 Ca(2+)-钙调蛋白的结合,但对 ATP 酶活性的抑制没有影响。用 PAK 对天冬氨酸突变体进行磷酸化导致 Thr-627、Ser-631、Ser-635 和 Ser-642 的缓慢磷酸化。这些位点的磷酸化进一步削弱了 Ca(2+)-钙调蛋白的结合,并降低了 Ca(2+)-钙调蛋白不存在时 CaD22 的抑制活性。CaD22 丙氨酸突变体这些位点的磷酸化对 Ca(2+)-钙调蛋白的结合没有影响,但确实降低了 ATP 酶活性的抑制。因此,残基 627 至 642 之间的区域可能有助于钙调蛋白活性的整体调节。